Last reviewed · How we verify
NCT03750123: CAVASAKI
Cardiovascular Status of Children 5 Years After Kawasaki Disease
trial in Vasculitis, Systemic in 61 participants. Completed in 28 September 2023.
28 September 2023
Quick facts
| Lead sponsor | Medical University of Warsaw |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 61 |
| Start date | 1 January 2019 |
| Primary completion | 28 September 2023 |
| Estimated completion | 28 September 2023 |
| Sites | 1 location across Poland |
Conditions studied
- Vasculitis, Systemic — all drugs for Vasculitis, Systemic →
- Kawasaki Disease — all drugs for Kawasaki Disease →
Sponsor
Medical University of Warsaw
Who can join
Adults 5 to 15, any sex, with Vasculitis, Systemic or Kawasaki Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of present study is to determine cardiovascular status of children who had KD in past and to identify possible biochemical markers of cardiovascular damage in those patients. In this cross-sectional study children with history of KD will be examined 5 years after receiving intravenous immunoglobulin treatment (IVIG) and compared to healthy controls in terms of: serum levels of endothelial injury markers (circulating endothelial cells, galectin-3, soluble VCAM), peripheral blood pressure, central blood pressure, arterial stiffness parameters (measured by applanation tonometry), carotid intima media thickness (cIMT), capillaroscopy and echocardiography.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Antibodies and Immunity During Kawasaki Disease.
Hicar MD. · · 2020 · cited 20× · PMID 32671098 · DOI 10.3389/fcvm.2020.00094
Verify or expand the search:
- PubMed search for NCT03750123
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Vasculitis, Systemic
Currently open trials in the same condition.
- NCT06807788 — Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis · active not recruiting
- NCT05879419 — Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases · Phase 4 · active not recruiting
Other Medical University of Warsaw trials
Trials by the same sponsor.
- NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
- NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
- NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
- NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
- NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03750123 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
- Last refreshed: 14 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03750123.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing